<?xml version="1.0" encoding="UTF-8"?>
<ref id="B11-molecules-25-02529">
 <label>11.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Joshi</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Joshi</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Sharma</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Mathpal</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Pundir</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Bhatt</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Chandra</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking</article-title>
  <source>Eur. Rev. Med. Pharmacol. Sci.</source>
  <year>2020</year>
  <volume>24</volume>
  <fpage>4529</fpage>
  <lpage>4536</lpage>
  <pub-id pub-id-type="doi">10.26355/eurrev_202004_21036</pub-id>
  <pub-id pub-id-type="pmid">32373991</pub-id>
 </element-citation>
</ref>
